在糖尿病微血管病症中Sirt1及其调节器的作用:一篇综述
Qi Jin1, Tongtong Liu1, Fang Ma1
1Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
International journal of biological macromolecules
|March 11, 2024
概括
准Sirt1,一个关键蛋白质,可能为糖尿病微血管病变提供新的治疗策略. 这种方法旨在预防和治疗糖尿病患者微血管功能受损引起的损伤.
科学领域:
- 内分泌学和新陈代谢学
- 血管生物学 血管生物学
- 分子生物学分子生物学
背景情况:
- 糖尿病微血管病包括微血管内皮功能受损,底层膜变厚和微血栓症,导致器官损伤.
- Sirt1是一种脱乙酶,调节包括氧化应激,炎症和衰老在内的细胞过程,并且在微血管病变中降低调节.
- 目前糖尿病并发症的预防和治疗策略不足,需要新的方法.
研究的目的:
- 审查糖尿病微血管病的背景和Sirt1.1的功能.
- 探索Sirt1与各种糖尿病微血管病变之间的关系.
- 总结Sirt1调节器作为改善糖尿病微血管病的潜在治疗点.
主要方法:
- 文献综述和对Sirt1和糖尿病微血管病症现有研究的综合.
- 在糖尿病并发症的背景下,分析Sirt1在不同细胞类型中的调节作用.
- 针对Sirt1.1的治疗调节器的识别和摘要.
主要成果:
- Sirt1在氧化应激和炎症中起着关键的调节作用,这是糖尿病微血管病的核心过程.
- 在血管损伤和微血管病变中,Sirt1的表达减少,这表明它起着保护作用.
- 针对Sirt1的调节器已被确定为改善糖尿病微血管病变的潜在药物.
结论:
- 针对Sirt1代表了糖尿病微血管病的有前途的新治疗策略.
- 了解Sirt1的调节机制对于开发有效的治疗方法至关重要.
- Sirt1调制为预防和治疗糖尿病血管并发症提供了潜在的途径.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32


